Foto del docente

Francesco Tovoli

Senior assistant professor (fixed-term)

Department of Medical and Surgical Sciences

Academic discipline: MED/09 Internal Medicine

Publications

De Lorenzo, Stefania; Tovoli, Francesco; Barbera, Maria Aurelia; Garuti, Francesca; Palloni, Andrea; Frega, Giorgio; Garajovà, Ingrid; Rizzo, Alessandro; Trevisani, Franco; Brandi, Giovanni, Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept, «SCIENTIFIC REPORTS», 2018, 8, Article number: 9997 , pp. 1 - 7 [Scientific article]Open Access

Renzulli M, Biselli M, Brocchi S, Granito A, Vasuri F, Tovoli F, Sessagesimi E, Piscaglia F, D'Errico A, Bolondi L, Golfieri R, New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm, «GUT», 2018, 67, pp. 1674 - 1682 [Scientific article]

Tovoli, Francesco; De Lorenzo, Stefania; Samolsky Dekel, Boaz G.; Piscaglia, Fabio; Benevento, Francesca; Brandi, Giovanni; Bolondi, Luigi, Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma, «LIVER INTERNATIONAL», 2018, 38, pp. 278 - 284 [Scientific article]

Tovoli, F; Granito, A; De Lorenzo, S; Bolondi, L, Regorafenib for the treatment of hepatocellular carcinoma, «DRUGS OF TODAY», 2018, 54, pp. 5 - 13 [Scientific article]

Serio, I.; Tovoli, F., Rheumatoid arthritis: New monoclonal antibodies, «DRUGS OF TODAY», 2018, 54, pp. 219 - 230 [Scientific article]

Tovoli, Francesco; Negrini, Giulia; Benevento, Francesca; Faggiano, Chiara; Goio, Elisabetta; Granito, Alessandro, Systemic treatments for hepatocellular carcinoma: challenges and future perspectives, «HEPATIC ONCOLOGY», 2018, 5, pp. 1 - 14 [Scientific article]

Tovoli, F.; Cantisani, V.; Schiavone, C.; Piscaglia, F.*, What Future for Ultrasound in Medicine?, «ULTRASCHALL IN DER MEDIZIN», 2018, 39, pp. 7 - 10 [Scientific article]

Tovoli, Francesco; Napoli, Lucia; Negrini, Giulia; D'Addato, Sergio; Tozzi, Giulia; D'Amico, Jessica; Piscaglia, Fabio; Bolondi, Luigi, A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2017, 18, Article number: 1134 , pp. 1 - 15 [Scientific article]

Brandi, Giovanni; De Lorenzo, Stefania; Palloni, Andrea; Biasco, Guido; Tovoli, Francesco, Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention, «HEPATOLOGY», 2017, 65, pp. 1075 - 1076 [Comment or similar]

Petta, S.; Cabibbo, G.; Barbara, M.; Attardo, S.; Bucci, L.; Farinati, F.; Giannini, E.G.; Tovoli, F.; Ciccarese, F.; Rapaccini, G.L.; Di Marco, M.; Caturelli, E.; Zoli, M.; Borzio, F.; Sacco, R.; Virdone, R.; Marra, F.; Felder, M.; Morisco, F.; Benvegnù, L.; Gasbarrini, A.; Svegliati-Baroni, G.; Foschi, F.G.; Olivani, A.; Masotto, A.; Nardone, G.; Colecchia, A.; Persico, M.; Boccaccio, V.; Craxì, A.; Bruno, S.; Trevisani, F.; Cammà, C.; the Italian Liver Cancer (ITA.LI.CA) Group: [.. ; Maurizio Biselli; Paolo Caraceni; Alessandro Cucchetti; Marco Domenicali; Fabio Piscaglia; Annagiulia Gramenzi; Alessandro Granito; Donatella Magalotti; Carla Serra; Giulia Negrini; Lucia Napoli; Veronica Salvatore; Francesca Benevento; ..], Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon, «ALIMENTARY PHARMACOLOGY & THERAPEUTICS», 2017, 45, pp. 160 - 168 [Scientific article]

Casadei Gardini, Andrea*; Faloppi, Luca; De Matteis, Serena; Foschi, Francesco Giuseppe; Silvestris, Nicola; Tovoli, Francesco; Palmieri, Vincenzo; Marisi, Giorgia; Brunetti, Oronzo; Vespasiani-Gentilucci, Umberto; Perrone, Giuseppe; Valgiusti, Martina; Granato, Anna Maria; Ercolani, Giorgio; Negrini, Giulia; Tamburini, Emiliano; Aprile, Giuseppe; Passardi, Alessandro; Santini, Daniele; Cascinu, Stefano; Frassineti, Giovanni Luca; Scartozzi, Mario, Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale, «EUROPEAN JOURNAL OF CANCER», 2017, 86, pp. 106 - 114 [Scientific article]

Brandi, Giovanni; De Lorenzo, Stefania; Candela, Marco; Pantaleo, Maria Abbondanza; Bellentani, Stefano; Tovoli, Francesco; Saccoccio, Gioconda; Biasco, Guido, Microbiota, NASH, HCC and the potential role of probiotics, «CARCINOGENESIS», 2017, 38, pp. 231 - 240 [Scientific article]

Tovoli, Francesco; De Lorenzo, Stefania; Barbera, Maria Aurelia; Garajova, Ingrid; Frega, Giorgio; Palloni, Andrea; Pantaleo, Maria Abbondanza; Biasco, Guido; Brandi, Giovanni, Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial, «FUTURE ONCOLOGY», 2017, 13, pp. 1893 - 1905 [Scientific article]

Tovoli, Francesco; Renzulli, Matteo; Granito, Alessandro; Golfieri, Rita; Bolondi, Luigi, Radiologic criteria of response to systemic treatments for hepatocellular carcinoma, «HEPATIC ONCOLOGY», 2017, 4, pp. 129 - 137 [Scientific article]

Galle, Peter R; Tovoli, Francesco; Foerster, Friedrich; Wörns, Marcus A; Cucchetti, Alessandro; Bolondi, Luigi, The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy, «JOURNAL OF HEPATOLOGY», 2017, 67, pp. 173 - 183 [Scientific article]

Latest news

At the moment no news are available.